PPT-Residual risk and HDL-cholesterol:
Author : bitsy | Published Date : 2022-06-28
What are the current perspectives Prof Erik Stroes Academic Medical Centre Amsterdam The Netherlands Is There a Therapeutic Need Beyond LDL Lowering 1 Heart
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Residual risk and HDL-cholesterol:" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Residual risk and HDL-cholesterol:: Transcript
What are the current perspectives Prof Erik Stroes Academic Medical Centre Amsterdam The Netherlands Is There a Therapeutic Need Beyond LDL Lowering 1 Heart Protection Study Collaborative Group. AANUIIOU WELL ALANEIELOWINAUAE fats trans fats and cholesterol that includes a VAIEYOUI VEGEALEANA EEANLOW A dairy products AOILYWIEPEWEE OOELEANUOMEA IMALLVIILEAANOW AWAYEAAOOOUOEMEAEMOVEE skin from poultry 3UIUEMEALEOLOW MEAMAINIEO regular entrees In fact the higher your blood cholesterol the greater your risk of developing heart disease or having a heart attack Heart disease is the 1 killer of men and women in the United States Each year more than a million Americans have a heart attack and and Their Relationship to Health. Mark Pettus MD. Medical Director Functional Formularies. Director Medical Education, Wellness and Population Health. Berkshire . H. ealth Systems. Learning Objectives. Victor Nadler. Objectives. By the end of this class, students will be able to. :. Explain the role of dietary lipids and endogenous lipoproteins, including dietary cholesterol, chylomicrons, VLDL-C, LDL-C, and . Arterio. sclerosis. Thickening/Hardening of Arteries. Predominantly . Athero. sclerosis. Normal vessel structure. Pathophysiology of Brain & Body . USSJJQ-20-3. Normal Structure. Normal Structure. Assist.Lecturer. Aseel. . Ghassan. . Daoud. M.Sc. in Pharmacy/Clinical Laboratory Sciences. What is HDL?. It is a high density lipoprotein, which is one of the classes of lipoproteins that carry cholesterol in the blood.. Dr. . Haidar. F. Al-. Rubaye. . Lipids are an essential nutrient with diverse functions. Lipids, also known as fats and oils, are:. One of the 6 main groups of nutrients absorbed from the diet. A major source of energy that can be stored over long periods (body fat). Featured Clinical Research – Late Breaking Clinical Trials . Residual Inflammatory Risk and Residual Cholesterol Risk Among Statin Treated Atherosclerosis Patients With and Without Chronic Kidney Disease:. QCERT. 5/8/2018. 1. Table of Content. Objective. ISRM Methodology. ISRM Scope. Top 10 IS Risks. Initial & Final Residual Risks. Risk Treatment Options. Key IS Risks. List of IS Risks . Retained. Avoided. , MD, FRCPC, FACP, CCD, ECNU.. Asst. Professor and Consultant . Medicine, Endocrinology. Department of Medicine, King Saud University. Lipid Transport. LPL/Apo C2. Rader DJ, Daugherty, A Nature 2008; 451:904-913 . An interpretation of the continuous relationship between LDL-C and CVD. Therefore, many men and . most. women with heart disease have lipid problems other than high total or LDL cholesterol that put them at risk for heart disease. . Gary E. Foresman, MD. January 2019. What Is Middle Path Medicine?. Gary E. Foresman, M.D.. : Board Certified Internal Medicine Physician, Board Certified Functional, Anti-Aging & Regenerative Medicine, Fellow Integrative Cancer Therapies, Founder and President of Middle Path Medicine . Assist.Lecturer. . Aseel. . Ghassan. . Daoud. M.Sc. In pharmacy/ Clinical laboratory sciences. What is cholesterol?. Cholesterol is a steroid that is essential for life.. What are the roles of cholesterol in the body?. , MD, FRCPC, FACP, CCD, ECNU.. Associate . Professor and Consultant . Medicine, Endocrinology. Department of Medicine, King Saud University. Lipid Transport. LPL/Apo C2. Rader DJ, Daugherty, A Nature 2008; 451:904-913 .
Download Document
Here is the link to download the presentation.
"Residual risk and HDL-cholesterol:"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents